Literature DB >> 25205791

Quality of life among adults with epidermolysis bullosa living with a gastrostomy tube since childhood.

Lynne D Hubbard1, Kattya Mayre-Chilton2.   

Abstract

Epidermolysis bullosa (EB) is a rare genetic condition characterized by blistering to the skin and internal mucous membranes arising from mild mechanical trauma. The impact on those affected can be significant. They might have increased nutritional requirements because of blistering, chronic wounds, infection, and loss of exudates, and nutritional intake might be compromised because of oropharyngeal blistering and strictures, resulting in malnutrition in many patients. Placement of gastrostomy tubes can help some patients meet nutritional requirements. We report a recent study on how EB patients and their families approached the issue of whether to have a gastrostomy tube placed and how such tubes affect quality of life. Our findings include important insights for clinicians and families about how patients experience life with a gastrostomy. We show how the process of consent can be improved and how patients with a gastrostomy tube can feel more in control of their lives.
© The Author(s) 2014.

Entities:  

Keywords:  content analysis; health outcomes; hereditary diseases; illness and disease; interviews; lived experience; quality of life

Mesh:

Year:  2014        PMID: 25205791     DOI: 10.1177/1049732314549029

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  3 in total

1.  Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.

Authors:  Aris Angelis; Panos Kanavos; Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Valentin Brodszky; Johann Matthias Graf von der Schulenburg; Karine Chevreul; Ulf Persson; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-23

Review 2.  Supporting sexuality for people living with epidermolysis bullosa: clinical practice guidelines.

Authors:  Alex King; Humphrey Hanley; Mark Popenhagen; Florencia Perez; Kerry Thompson; Diana Purvis; Nora Garcia; Ida Steinlein; Mia Werkentoft; Matthew Lightfoot; Michelle Lahat; Kalsoom Begum; Julio Tanabe
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

3.  Efficacy of gentamicin 0.3% solution of oral erosions healing in patients with severe generalized recessive dystrophic epidermolysis bullosa and its impact on the expression of type VII collagen.

Authors:  Katarzyna Osipowicz; Piotr Wychowanski; Pawel Nieckula; Sara Shamsa; Katarzyna Wertheim-Tysarowska; Katarzyna Wozniak; Cezary Kowalewski
Journal:  Postepy Dermatol Alergol       Date:  2020-07-14       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.